An Insight into the Current Status of the Radiotherapy Landscape in Africa: A Cross-sectional Survey Study on the Available Infrastructure and Human Resources

Main Article Content

Abba Mallum Wilbert Sibanda Maureen Bilinga Tendwa John M. Akudugu Wilfred Ngwa L. Incrocci Mariza Vorster

Abstract

Radiotherapy infrastructure and human capital are crucial for effective cancer control, yet their availability in Africa remains severely limited. This study addresses this critical gap in knowledge by providing a comprehensive assessment of radiotherapy resources across the continent.  A cross-sectional descriptive web-based survey was conducted using the Research Electronic Data Capture (REDCap) system, a secure and validated online survey platform. The survey questionnaires which adhered to Content Relevance, Order, Source, and style were disseminated via email and WhatsApp to a representative sample of health professionals in 54 African countries. Data was collected through the REDCap survey while descriptive statistical methods were employed to analyze the data. In this study, 25 countries (46.3%) participated, revealing a distribution of 43 Linear Accelerators (LINAC) and 18 Cobalt-60 machines. Southern Africa (30.2%) and North Africa (30.2%) led in LINAC availability, while East Africa (38.8%) had a higher representation of Cobalt-60 machines. The healthcare practitioner distribution across Africa highlighted that the majority (35.3%) had less than four years of experience, with a minority (21.9%) having approximately 11-20 years of experience. A smaller percentage (6.0%) had over 20 years of experience, and the fewest individuals were still in training (5.0%). Most countries recorded over 20 newly diagnosed breast, cervical, and prostate cancer patients per month. North Africa had the highest proportion of practitioners administering the highest fractional dose (8.0 – 12.0 Gy). Notably, Cameroon had the longest waiting time (10.4±7.6 weeks), while South Africa had the shortest waiting time (4.0±3.0 weeks). The scarcity of radiotherapy machines and human resources in Africa is apparent, potentially leading to prolonged waiting times for patients before treatment initiation, particularly given the high incidence of more than 20 newly diagnosed patients per month in most countries. This survey underscores the urgent need to address identified gaps to improve access to both radiotherapy and human resources across the continent.

Keywords: Human capacity, Radiotherapy infrastructure, Survey, LINAC, Cobalt-60

Article Details

How to Cite
MALLUM, Abba et al. An Insight into the Current Status of the Radiotherapy Landscape in Africa: A Cross-sectional Survey Study on the Available Infrastructure and Human Resources. Medical Research Archives, [S.l.], v. 12, n. 11, nov. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5749>. Date accessed: 12 dec. 2024. doi: https://doi.org/10.18103/mra.v12i11.5749.
Section
Research Articles

References

1 Ngwa, W. et al. Cancer in sub-Saharan Africa: a lancet oncology commission. The Lancet Oncology 23, e251-e312 (2022). https://doi.org/10.1016/S1470-2045(21)00720-8.
2 Ndlovu, N. Radiotherapy treatment in cancer control and its important role in Africa. Ecancermedicalscience 13 (2019). https://doi.org/10.3332/ecancer.2019.942.
3 Kruk, M. E., Gage, A. D., Joseph, N. T., Danaei, G., García-Saisó, S. & Salomon, J. A. Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. The Lancet 392, 2203-2212 (2018). https://doi.org/10.1016/S0140-6736(18)31668-4.
4 Ramutumbu, N. J., Ramathuba, D. U. & Maputle, M. S. Barriers to accessing oncology services for effective cancer care in the public health institutions in Limpopo Province, South Africa: a qualitative study. Nursing Reports 13, 956-968 (2023). https://doi.org/10.3390/nursrep13030084
5 Sharma, R., Fronterre, C., Ssentongo, A. E., Yenney, K., Amponsah-Manu, F. & Ssentongo, P. Mapping cancer in Africa: a comprehensive and comparable characterization of 34 cancer types using estimates from GLOBOCAN 2020. Frontiers in public health 10, 839835 (2022). https://doi.org/10.3389/fpubh.2022.839835.
6 Orem, J. Building modern cancer care services in sub-Saharan Africa based on a clinical-research care model. Am Soc Clin Oncol Educ Book 42, 1-6 (2022). https://doi.org/10.1200/edbk_349953.
7 Debela, D. T. et al. New approaches and procedures for cancer treatment: Current perspectives. SAGE open medicine 9, 20503121211034366 (2021). https://doi.org/10.1177/20503121211034366.
8 Baskar, R., Lee, K. A., Yeo, R. & Yeoh, K.-W. Cancer and radiation therapy: current advances and future directions. International journal of medical sciences 9, 193 (2012). https://doi.org/10.7150/ijms.3635.
9 Koka, K., Verma, A., Dwarakanath, B. S. & Papineni, R. V. Technological advancements in external beam radiation therapy (EBRT): An indispensable tool for cancer treatment. Cancer Management and Research, 1421-1429 (2022). https://doi.org/10.2147/CMAR.S351744.
10 Skowronek, J. Current status of brachytherapy in cancer treatment–short overview. Journal of contemporary brachytherapy 9, 581-589 (2017). https://doi.org/10.5114/jcb.2017.72607.
11 Bernier, J., Hall, E. J. & Giaccia, A. Radiation oncology: a century of achievements. Nature Reviews Cancer 4, 737-747 (2004). https://doi.org/10.1038/nrc1451
12 Symonds, R. Radiotherapy. BMJ 323, 1107-1110 (2001). https://doi.org/10.1136/bmj.323.7321.1107.
13 Spaide, R. F. et al. External beam radiation therapy for CNV: Authors’ reply. Ophthalmology 105, 1791-1792 (1998). https://doi.org/10.1016/s0161-6420(98)90980-0.
14 Lee, T.-F., Yang, J., Wuu, C.-S., Liu, A., Fang, F.-M. & Yeh, S.-A. Radiation oncology and medical physics. BioMed Research International 2015 (2015). https://doi.org/10.1155/2015/297158.
15 Brahme, A. in Technical Basis of Radiation Therapy: Practical Clinical Applications 219-251 (Springer, 2011). https://doi.org/10.1016/j.ijrobp.2003.09.034
16 Michalski, J. M. et al. Effect of brachytherapy with external beam radiation therapy versus brachytherapy alone for intermediate-risk prostate cancer: NRG oncology RTOG 0232 randomized clinical trial. Journal of Clinical Oncology 41, 4035-4044 (2023). https://doi.org/10.1200/JCO.22.01856.
17 Rosenblatt, E. & Zubizarreta, E. Radiotherapy in cancer care: facing the global challenge. (International Atomic Energy Agency Vienna, 2017). http://www.iaea.org/books.
18 Elmore, S. N. et al. Radiotherapy resources in Africa: an International Atomic Energy Agency update and analysis of projected needs. The Lancet Oncology 22, e391-e399 (2021). https://doi.org/10.1016/S1470-2045(21) 00351-X
19 Ige, T. et al. Understanding the challenges of delivering radiotherapy in low-and middle-income countries in Africa. Journal of Cancer Policy 35, 100372 (2023).
20 Balogun, O., Rodin, D., Ngwa, W., Grover, S. & Longo, J. in Seminars in radiation oncology. 184-188 (Elsevier). https://doi.org/10.1016/j.jcpo.2022.100372
21 I. A. E. Agency, s. IAEA Syllabus for the Education and Training of Radiation Oncologist. (2009). https://www-pub.iaea.org/MTCD/publications/PDF/TCS-36_web.pdf.
22 T. Ganesh (2007) A Syllabus for the education and training of radiation oncology nurses. (Wolters Kluwer Medknow Publications Wolters Kluwer India PVT LTD, A-202, 2nd, 2007). https://www.iaea.org/publications/7757/a-syllabus-for-the-education-and-training-of-radiation-oncology-nurses.
23 Donkor, A., Luckett, T., Aranda, S., Vanderpuye, V. & Phillips, J. Experiences of barriers and facilitators to establishing and sustaining radiotherapy services in low‐and middle‐income countries: A qualitative study. Asia‐Pacific Journal of Clinical Oncology 16, e74-e85 (2020). https://doi.org/10.1111/ajco.13310
24 Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 71, 209-249 (2021). https://doi.org/10.3322/caac.21660.
25 Horton, S. & Gauvreau, C. L. Cancer in low-and middle-income countries: an economic overview. Cancer: disease control priorities 3, 263-280 (2015). https://doi.org/10.1596/978-1-4648-0349-9_ch16 .
26 James, S. S. et al. Current status of radiopharmaceutical therapy. International Journal of Radiation Oncology* Biology* Physics 109, 891-901 (2021). https://doi.org/10.1016/j.ijrobp.2020.08.035
27 Borrego-Soto, G., Ortiz-López, R. & Rojas-Martínez, A. Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer. Genetics and molecular biology 38, 420-432 (2015). https://doi.org/10.1590/S1415-475738420150019.
28 Maitre, P. et al. Modern radiotherapy technology: obstacles and opportunities to access in low-and middle-income countries. JCO Global Oncology 8, e2100376 (2022). https://doi.org/10.1200/GO.21.00376
29 Zubizarreta, E., Fidarova, E., Healy, B. & Rosenblatt, E. Need for radiotherapy in low and middle income countries–the silent crisis continues. Clinical oncology 27, 107-114 (2015). https://doi.org/10.1016/j.clon.2014.10.006
30 Abdel-Wahab, M. et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. The lancet oncology 14, e168-e175 (2013). https://doi.org/10.1016/S1470-2045(12)70532-6.
31 Berumen, A. V., Moyao, G. J., Rodriguez, N. M., Ilbawi, A. M., Migliore, A. & Shulman, L. N. Defining priority medical devices for cancer management: a WHO initiative. The lancet oncology 19, e709-e719 (2018). https://doi.org/10.1016/S1470-2045(18)30658-2
32 Leng, J., Ntekim, A. I., Ibraheem, A., Anakwenze, C. P., Golden, D. W. & Olopade, O. I. Infrastructural challenges lead to delay of curative radiotherapy in Nigeria. JCO global oncology 6, 269-276 (2020). https://doi.org/10.1200/JGO.19.00286.
33 Christ, S. M. & Willmann, J. Measuring global inequity in radiation therapy: Resource deficits in low-and middle-income countries without radiation therapy facilities. Advances in Radiation Oncology 8, 101175 (2023). https://doi.org/10.1016/j.adro.2023.101175.
34 Drokow, E. K. et al. Cervical cancer survival times in Africa. Frontiers in Public Health 10, 981383 (2022). https://doi.org/10.1002/sd.2639
35 Elmore, S. N., Sethi, R. V., Viswanathan, A. N. & Efstathiou, J. A. Global radiation oncology from the trainee perspective: A view from beyond the bunker. International journal of radiation oncology, biology, physics 94, 438-439 (2016). https://doi.org/10.1016/j.ijrobp.2015.11.033
36 Atun, R. et al. Expanding global access to radiotherapy. The lancet oncology 16, 1153-1186 (2015). https://doi.org/10.1016/S1470-2045(15)00222-3
37 Jaffray, D. A. et al. Global task force on radiotherapy for cancer control. The lancet oncology 16, 1144-1146 (2015). https://doi.org/10.1016/S1470-2045(15)00285-5
38 Jedy-Agba, E., McCormack, V., Adebamowo, C. & dos-Santos-Silva, I. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health 4, e923-e935 (2016). https://doi.org/10.1016/S2214-109X(16)30259-5
39 Fisher BJ, Daugherty LC, Einck JP, Suneja G, Shah MM, Dad LK, Mutter RW, Wilkinson JB, Mundt AJ., Radiation oncology in Africa: improving access to cancer care on the African continent. International Journal of Radiation Oncology* Biology* Physics 89, 458-461 (2014). https://doi.org/10.1016/j.ijrobp.2013.12.032 .